← All topics

Weight-loss medicines

GLP-1 drugs made obesity genetics a dinner-table subject.

Why this topic GLP-1 drugs went from clinic to conversation in two years.

What this topic connects to

Weight-loss medicines Variant: rs9939609 rs9939609 Variant Variant: rs987237 rs987237 Variant Variant: rs662799 rs662799 Variant Variant: rs10423928 rs10423928 Variant Variant: rs1800437 rs1800437 Variant Variant: +1 more +1 more Variant Weight-loss medicines Weight-loss medicines

Solid lines are connections this site curates. Dashed lines are topics: the variant and the subject share a research paper, which is worth knowing and is not a claim that one explains the other.

Variants that share a paper with this

Counted in Europe PMC, where the title or abstract names both this topic and that rsID. The number is papers, not evidence of a cause.

rs9939609

FTO

Menarche (age at onset)

8 papers →

rs987237

TFAP2B

Adiposity

3 papers →

rs662799

APOA5

Triglyceride levels

2 papers →

rs10423928

GIPR

Obesity

1 paper →

rs1800437

GIPR

Obesity

1 paper →

rs9930506

FTO

Obesity-related traits

1 paper →

How this was counted

Europe PMC, title and abstract only, searched for “semaglutide”, “GLP-1 receptor agonist”, “tirzepatide”, “weight loss intervention” alongside each published rsID. Full text was not counted: it returns every paper with an rsID buried in a supplementary table. Recounted monthly.